Occlusion device
AssigneeCerus Endovascular Limited
InventorStephen Griffin
Life of this patent
Estimating the term…
Abstract
Provided herein is an occlusion device comprising: (a) a substantially solid marker band having an inner and outer diameter, a proximal end, and a distal end; and (b) a resilient mesh body attached within the marker band, wherein the body is a length y, and wherein the body comprises a bolus of additional resilient mesh material of a length x, wherein y is greater than x, and wherein the body extends distally from the marker band having a first delivery shape and a second expandable deployed shape. Also provided herein is a kit comprising the occlusion device disclosed herein and a means for delivery thereof. Methods of manufacture and use of the occlusion device disclosed herein are also disclosed.
Claims17
An occlusion device comprising:
- (a) a substantially solid marker band having an inner and outer diameter, a proximal end, and a distal end;
- and (b) a resilient mesh body attached within the marker band, wherein the body is a length y, and wherein the body comprises a bolus of additional resilient mesh material of a length x, wherein y is greater than x, and wherein the body extends distally from the marker band having a first delivery shape and a second expandable deployed shape.
A method for treating or ameliorating Left Atrial Appendage (LAA) in a patient, the method comprising:
- i.) delivering to an LAA an occlusion device, wherein the device comprises (a) a substantially solid marker band having an inner and outer diameter, a proximal end, and a distal end;
- and (b) a resilient mesh body attached within the marker band, wherein the body is a length y, and wherein the body comprises a bolus of additional resilient mesh material of a length x, wherein y is greater than x, and wherein the body extends distally from the marker band having a first delivery shape and a second expandable deployed shape;
- and
- ii.) deploying the occlusion device in the LAA, thereby treating or ameliorating LAA in the patient.
Dependencies are inferred from the claim text.